T helper 2 and regulatory T-cell cytokine production by mast cells: A key factor in the pathogenesis of IgG4-related disease

Modern Pathology

Volumn 27, Issue 8, 2014, Pages 1126-1136

  Takeuchi, Mai ^a   Sato, Yasuharu ^a   Ohno, Kyotaro ^a   Tanaka, Satoshi ^a   Takata, Katsuyoshi ^a   Gion, Yuka ^a   Orita, Yorihisa ^a   Ito, Toshihiro ^a   Tachibana, Tomoyasu ^b   Yoshino, Tadashi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HIMEJI RED CROSS HOSPITAL   (Japan)

Author keywords

cytokine; IgE; IgG4 related disease; mast cells; regulatory T cell

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER; CYTOKINE; IMMUNOGLOBULIN G; MESSENGER RNA;

ALLERGIC REACTION; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOHISTOCHEMISTRY; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SALIVARY GLAND DISEASE; SIALOLITHIASIS; STAINING; TH2 CELL; UPREGULATION; IMMUNOFLUORESCENCE TEST; SUBMANDIBULAR GLAND; BLOOD; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MAST CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLAND CALCULI; SUBMANDIBULAR GLAND; SUBMANDIBULAR GLAND DISEASES; T-LYMPHOCYTES, REGULATORY; TH2 CELLS;

EID: 84905441200     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.236     Document Type: Article

References (28)

1. Umehara H, Okazaki K, Masaki Y, et al. A novel clinical entity IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012;22:1-14.
2. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012;25:1181-1192.
3. Sato Y, Inoue D, Asano N, et al. Association between IgG4-related disease and progressively transformed germinal centers of lymph nodes. Mod Pathol 2012;25:956-967.
4. Sato Y, Takeuchi M, Takata K, et al. Clinicopathologic analysis of IgG4-related skin disease. Mod Pathol 2012;26:523-532.
5. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-1546.
6. Tanaka A, Moriyama M, Nakashima H, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum 2012;64:254-263.
7. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010; 62:1755-1762.
8. Gri G, Frossi B, D'Inca F, et al. Mast cell: an emerging partner in immune interaction. Front Immunol 2012;3:120.
9. Amin K. The role of mast cells in allergic inflammation. Respir Med 2012;106:9-14.
10. Kashiwakura J, Kawakami Y, Yuki K, et al. Polyclonal IgE induces mast cell survival and cytokine production. Allergol Int 2009;58:411-419.
11. Nakashima H, Miyake K, Moriyama M, et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol 2010;73:385-391.
12. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
13. Miyao T, Floess S, Setoguchi R, et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012;36:262-275.
14. Da Silva Martins M, Piccirillo CA. Functional stability of Foxp3+ regulatory T cells. Trends Mol Med 2012; 18:454-462.
15. Zhang W, Wu K, He W, et al. Transforming growth factor beta 1 plays an important role in inducing CD4(+) CD25(+) forhrad box P3(+) regulatory t cells by mast cells. Clin Exp Immunol 2010;161: 490-496.
16. Sato Y, Notohara K, Kojima M, et al. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 2010;60:247-258.
17. Bax HJ, Keeble AH, Gould HJ. Cytokinergic IgE action in mast cell activation. Front Immunol 2012;3:229.
18. Burton OT, Oettgen HC. Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases. Immunol Rev 2011;242:128-143.
19. Fattakhova GV, Masilamani M, Nrayanan S, et al. Endosomal trafficking of the ligated FCeRI receptor. Mol Immunol 2009;46:793-802.
20. Ohshima K, Sato Y, Yoshino T. A case of IgG4-related dacryoadenitis regressed without systemic steroid administration. J Clin Exp Hematol 2013;53:53-56.
21. Cuss FM. Beyond the histamine receptor: effect of antihistamines on mast cells. Clin Exp Allergy 1999; 29:4-59.
22. Galatowicz G, Ajayi Y, Stern ME, et al. Ocular antiallergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo. Clin Exp Allergy 2007;37:1648-1656.
23. Khosroshahi A, Carruthers MN, Deshpande V, et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Med Baltimore 2012;91:57-66.
24. Wong PC, Fung AT, Gerrie AS, et al. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. Eur J Haematol 2012;90:250-256.
25. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol 2009;21:487-492.
26. Tsuneyama K, Kono N, Yamashiro M, et al. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis. J Pathol 1999;189:609-614.
27. Tsuneyama K, Saito K, Ruebner BH, et al. Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis. Dig Dis Sci 2000;45:366-372.
28. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet. B Nat Immunol 2007;8: 1095-1104.